Feb 28, 2019 / 04:30PM GMT
Danielle Joy Antalffy - SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Analyst
Okay. Let's get started. Good morning, everyone. My name's Danielle Antalffy. I am one of the medtech analysts here at SVB Leerink. And we are very lucky to have with us from Boston Scientific, Joe Fitzgerald. He is EVP and President of Rhythm Management; as well as Susie Lisa, Head of Investor Relations. And this is going to be fireside chat format, should we just launch right into Q&A? And if anyone has a question, feel free to raise your hand. And if you're lucky, maybe I'll call on you. No, I'm kidding.
Questions and Answers:
Danielle Joy Antalffy - SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior AnalystOkay. So Joe, at your Analyst Day, you talked about Rhythm Management being a $14 billion market, growing at about 3%. Can you talk about any possible market adjacencies that could potentially grow this addressable market? And given your category leadership strategy, what's the right way to think